Mitral regurgitation occurring during methsergide (Sansert) therapy.
The case history of a young woman who developed severe mitral regurgitation after four years of methysergide therapy is reported. Replacement of the mitral valve was required. A brief review of the toxic effects of methysergide is given and special reference is made to lesions of the heart valves that have occurred during methysergide therapy.
D000328:Adult; D000792:Angiography; D005260:Female; D006350:Heart Valve Prosthesis; D006801:Humans; D008784:Methysergide / Q000009:adverse effects*; D008881:Migraine Disorders / Q000188:drug therapy*; D008944:Mitral Valve Insufficiency / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery; D011183:Postoperative Complications
D008784:Methysergide